News
IBA partners with Jubilant Radiopharma, selling five Cyclone® KIUBE to support their PET radioisotope production across the US
IBA partners with Jubilant Radiopharma, selling five Cyclone® KIUBE to support their PET radioisotope production across the US
See moreIBA and Jules Bordet Institute to lead IHI project Accelerate.EU to create complete Astatine-211 value chain
IBA, the world leader in particle accelerator technology and the world’s leading provider of radiopharmaceutical production solutions, today announces its business update for the first quarter ending 31 March 2024.
See moreIBA Reports Half Year 2024 Results
IBA, the world leader in particle accelerator technology and the world’s leading provider of radiopharmaceutical production solutions, today announces its business update for the first quarter ending 31 March 2024.
See more
Rigging of the Cyclone® KIUBE at AMS Pharmaceutical in China
Rigging of the Cyclone® KIUBE at AMS Pharmaceutical in China
See moreIBA Business Update – First Quarter 2024
IBA, the world leader in particle accelerator technology and the world’s leading provider of radiopharmaceutical production solutions, today announces its business update for the first quarter ending 31 March 2024.
See more
IBA Radio Pharma Solutions delegation in Japan
In March, a delegation of IBA Radio Pharma Solutions took the opportunity to be in Japan to visit our customers JFE Engineering Corporation, Sceti K.K., CMI and PDRadiopharma Inc.
See moreIBA Reports Full Year 2023 Results
IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology, today announces its consolidated results for the 2023 financial year. [...]
See more
Rigging of the Cyclone® KIUBE and its self-shielding at CHU Liège, Belgium
Rigging of the Cyclone® KIUBE and its self-shielding at CHU Liège, Belgium
See more
WEBINAR ON DEMAND | Setting up a cyclotron radiopharmacy: Navigating the challenges through two case studies
Webinar with Dr. Richard Freifelder and get an in-depth understanding of setting up a cyclotron radiopharmacy. He shares his experience of setting up a cyclotron radiopharmacy by navigating the challenges in 2 different scenarios: green field and legacy space focusing on the challenges and opportunities of each towards GMP compliance.
See more